Association of social determinants with the severity of congenital heart disease

Mario J Forero-Manzano1,2,3, Eddy Triana-Palencia2, Jenny A Figueroa-Rueda2

  • 1Neumología Pediátrica, Hospital Internacional de Colombia HIC - Instituto Cardiovascular, Fundación Cardiovascular de Colombia, Piedecuesta, Santander, Colombia.

Pediatric Research
|August 19, 2022
PubMed

Insights

Maternal exposure to cigarette and wood smoke, along with low socioeconomic status, are key social determinants linked to increased congenital heart disease severity in children. Public health policies should focus on reducing these exposures during pregnancy.

Area of Science:

  • Public Health
  • Pediatrics
  • Epidemiology

Background:

  • Congenital heart diseases (CHDs) are the leading cause of mortality in newborns and infants.
  • Understanding the social determinants of CHD severity is crucial for targeted interventions.

Purpose of the Study:

  • To analyze social determinants associated with the severity of congenital heart disease in children.
  • To identify risk factors within family environments impacting CHD outcomes.

Main Methods:

  • An analytical cross-sectional study was conducted with 140 families of children diagnosed with CHD.
  • A structured survey assessed family structure, health, economic conditions, and environmental exposures.
  • Data was collected over a one-year period.

Main Results:

  • Low socioeconomic status was prevalent in 53.7% of the studied population.
  • Maternal exposure to cigarette and wood smoke during pregnancy was associated with increased CHD severity.
  • Only 22% of CHDs were diagnosed prenatally, with 28.3% of mothers having fewer than four prenatal visits.

Conclusions:

  • Maternal smoking, wood smoke exposure, and low socioeconomic status are significant social determinants of CHD severity.
  • These factors are particularly relevant when analyzing disease by pathophysiological groups (cyanotic/non-cyanotic/single ventricle).
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
39
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
47
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
47
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
27
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
45
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K